{"SPADE_UN_10171": {"Clinical Information": [], "Patent Information": [{"Patent No": "US 7556813 B2", "Patent Link": "http://www.lens.org/lens/patent/US_7556813_B2", "Patent Type": "Granted Patent", "Publication Date": "2009-7-7", "Family Info": "CA2497767A1,CN1684972A,EP1554306A2,EP1554306A4,US20040122214,US20100016225,WO2004029073A2,WO2004029073A3", "Patent Title": "Antiviral peptide-polymer conjugate comprising a polymer covalently attached to two or more synthetic HIV gp41 HR1 and/or HR2 peptides.", "Abstract": "Provided are conjugates comprising a polymer having operably bound thereto no less than two molecules of synthetic peptide derived from HIV gp41; methods of using these conjugates to inhibit transmission of HIV to a target cell by adding an amount of effective to inhibit infection of the cell by the virus; and methods of producing the conjugates by operably binding each molecule of synthetic peptide, via a reactive functionality, to the polymer."}], "Sequence Information": {"SPADE ID": "SPADE_UN_10171", "Sequence": "WQEWDREITALLEQAQIQQEKNEYELQKLDKWASLWNWF", "Sequence Length": 39, "Peptide Name": "Sequence 51 from Patent US 7556813", "Source": "Synthetic construct", "Biological Activity": ["Antimicrobial", "Antiviral"], "Frequent Amino Acids": "EQL", "Absent Amino Acids": "CGHMOPUV", "Basic Residues": 4, "Acidic Residues": 8, "Hydrophobic Residues": 17, "Polar Residues": 18, "Positive Residues": 4, "Negative Residues": 8, "Mass": 4995.47, "PI": 4.38, "Net Charge": -4, "Hydrophobicity": -1.11, "Similar Sequences": [{"SPADE_ID": "SPADE_UN_10277", "Similarity": 1.0, "Sequence": "LDKWASLWNWF"}, {"SPADE_ID": "SPADE_UN_10278", "Similarity": 1.0, "Sequence": "DKWASLWNWF"}, {"SPADE_ID": "SPADE_UN_10279", "Similarity": 1.0, "Sequence": "KWASLWNWF"}]}}}